A mechanistic model captures the emergence and implications of non-genetic heterogeneity and reversible drug resistance in ER+ breast cancer cells

Resistance to anti-estrogen therapy is an unsolved clinical challenge in successfully treating ER+ breast cancer patients. Recent studies have demonstrated the role of non-genetic (i.e. phenotypic) adaptations in tolerating drug treatments; however, the mechanisms and dynamics of such non-genetic ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Sahoo, Sarthak, Mishra, Ashutosh, Kaur, Harsimran, Hari, Kishore, Muralidharan, Srinath, Mandal, Susmita, Jolly, Mohit Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Cancer Computational Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8271219/
https://www.ncbi.nlm.nih.gov/pubmed/34316714
http://dx.doi.org/10.1093/narcan/zcab027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8271219/
https://www.ncbi.nlm.nih.gov/pubmed/34316714
http://dx.doi.org/10.1093/narcan/zcab027

Ejemplares similares